After years of collecting consumer DNA, genetic testing companies are monetizing the data. But who should profit — the ...

Could synthetic macrocyclic peptides be the Next Big Thing to lift biotech? A potential $1.5 billion deal suggests things are ...

The most obvious use for genetic data is discovering one’s health predispositions; 23andMe offers a subscription that shows whether a person’s DNA is associated with a likelihood for certain ...

A bankruptcy court approved the $305M sale of 23andMe to a nonprofit led by Anne Wojcicki, raising questions about data ...

“Your DNA and your family health history should not be a corporate asset," said J.B. Branch, Big Tech accountability advocate for the consumer rights advocacy group Public Citizen, in a statement.

DNA isn’t just for genetics anymore—it’s shaping up to be the ultimate storage device, especially for your photographs.

Listen to more stories on the Noa app. DNA might contain health information, but unlike a doctor’s office, 23andMe is not bound by the health-privacy law HIPAA. And the company’s privacy ...

It's unclear what's next for 23andMe, but experts say there's a big incentive for corporations and researchers alike to get their hands on the company's trove of genetic data.

What could happen to the DNA data of its 14 million customers? National. 23andMe is in trouble. ... But there was one big business problem - nobody needed to do a 23andMe test twice. It was one ...

The most obvious use for genetic data is discovering one's health predispositions; 23andMe offers a subscription that shows whether a person's DNA is associated with a likelihood for certain ...

It’s unclear what’s next for 23andMe, but experts say there’s a big incentive for corporations and researchers alike to get their hands on the company’s trove of genetic data.